ArticleJournal of applied genetics2026
miRNA-mRNA network analysis reveals novel post-transcriptional regulators and therapeutic targets in coronary artery disease.
Article in Journal of applied genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Coronary artery disease (CAD) remains one of the leading causes of mortality worldwide, driven by complex gene regulatory mechanisms. Non coding RNAs such as microRNAs (miRNAs) act as pivotal regulators of CAD pathogenesis. This study employed a multi-omics in silico approach to uncover microRNA (miRNA)-mediated regulatory networks in CAD. Differentially expressed miRNAs were identified from patient cohorts and mapped to target genes. Overlapping common genes (OCGs) between predicted targets and CAD-associated DEGs were used to construct a regulatory network. Hub miRNAs were prioritized, identifying 20 key regulators, including 11 novel hub-level regulatory candidates not previously prioritized as master regulators in integrated CAD miRNA network analyses. Functional enrichment confirmed the involvement of these OCGs in atherosclerosis and cardiomyopathy. A competing endogenous miRNA-lncRNA network was built to explore multi-layered regulation. Possible drug targets were analyzed to assess therapeutic potential for the results. This integrative pipeline offers insights into miRNA-driven CAD mechanisms and highlights novel biomarkers and targets for clinical implementation.
Indexed as
Identifiers
42162444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.